Genomma Lab

in implementation

The Project with Genomma Lab has two components: (i) an Uncommitted Revolving Line of Credit for MX$200 million, or its equivalent in US$ (“Facility”) to purchase accounts payables issued by Genomma Lab or one of its eligible subsidiaries. The Facility will have an initial tenor of 12 months, renewable on a yearly basis at IDB Invest’s discretion for up to 6 additional years, and (ii) a long-term loan for up to MX$1.0 billion (“Long-Term Loan”) to finance the construction, equipment and operation of its new manufacturing plant in Toluca, Estado de México.The Facility will provide Genomma Lab’s suppliers with an innovative alternate solution to finance their working capital needs, using E-Factor Network platform to sell to IDB Invest Genomma Lab’s accounts payables. This solution will enable Genomma Lab’s suppliers (including small and medium size companies, “SME’s”), to obtain financing in much favorable conditions than those they can obtain in the local market on their own. SME’s Supply Chain Financing through corporates like Genomma Lab is one of the ways IDB Invest will focus in this segment. This kind of solutions are aligned with IDB Invest’s innovative approach with SME’s.The Long-Term Loan will finance Genomma Lab’s new manufacturing plant. This new facility will have an important developmental impact, including the following: (a.) job creation, (b.) hard currency generation, (c.) establishment of a new productive Cluster, and (d.) installation of a new state of the art manufacturing plant.